ArticleEpidemiology and infection2014
Evolutionary history of Ebola virus.
Article in Epidemiology and infection, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed.
- The Ebola virus - going beyond the bleeding edge.Journal of medical microbiology · 2025Review
- A comprehensive overview on the crosstalk between microRNAs and viral pathogenesis and infection.Medicinal research reviews · 2025Review
- Continental concerted efforts to control the seventh outbreak of Ebola Virus disease in Uganda: The first 90 days of the response.Journal of public health in Africa · 2023Article
- Emergent Risk Group-4 (RG-4) Filoviruses: A paradox in progress.Bioinformation · 2023Article
- Ebola in the Eastern Democratic Republic of Congo: One Health approach to infectious disease control.One health (Amsterdam, Netherlands) · 2020Article
- Conserved microsatellites may contribute to stem-loop structures in 5', 3' terminals of Ebolavirus genomes.Biochemical and biophysical research communications · 2019Article
- Applications of gold nanoparticles in virus detection.Theranostics · 2018Review
- Human monoclonal antibodies as candidate therapeutics against emerging viruses.Frontiers of medicine · 2017Review
- Flavivirus and Filovirus EvoPrinters: New alignment tools for the comparative analysis of viral evolution.PLoS neglected tropical diseases · 2017Article
- New Perspectives on Ebola Virus Evolution.PloS one · 2016Article
- Highly conserved regions in Ebola virus RNA dependent RNA polymerase may be act as a universal novel peptide vaccine target: a computational approach.In silico pharmacology · 2015Article
- Article
- Ebola virus outbreak, updates on current therapeutic strategies.Reviews in medical virology · 2015Review
- Impact of spatial dispersion, evolution, and selection on Ebola Zaire Virus epidemic waves.Scientific reports · 2015Article
- One-Step Reverse-Transcription FRET-PCR for Differential Detection of Five Ebolavirus Species.PloS one · 2015Article
- What is Ebola?International journal of clinical practice · 2015Article
- Ebolavirus Evolution: Past and Present.PLoS pathogens · 2015Review
- Ocular Manifestations of Ebola Virus Disease: An Ophthalmologist's Guide to Prevent Infection and Panic.BioMed research international · 2015Review
- Antiviral therapies against Ebola and other emerging viral diseases using existing medicines that block virus entry.F1000Research · 2015Article
- Ebola virus (EBOV) infection: Therapeutic strategies.Biochemical pharmacology · 2015Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
summarySince Ebola virus was discovered in 1970s, the virus has persisted in Africa and sporadic fatal outbreaks in humans and non-human primates have been reported. However, the evolutionary history of Ebola virus remains unclear. In this study, 27 Ebola virus strains with complete glycoprotein genes, including five species (Zaire, Sudan, Reston, Tai Forest, Bundibugyo), were analysed. Here, we propose a hypothesis of the evolutionary history of Ebola virus which will be helpful to investigate the molecular evolution of these viruses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.